Compare Atomera Incorporated (ATOM) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Atomera Incorporated vs Regeneron Pharmaceuticals Inc — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while Regeneron Pharmaceuticals Inc trades at $655.5 (market cap $69.52B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 287.3× Atomera Incorporated's market cap, and Regeneron Pharmaceuticals Inc pays a 0.57% dividend while Atomera Incorporated pays none. Which is the better fit depends on your goals.
| ATOM | REGN | |
|---|---|---|
Market Cap | $241.98M | $69.52B |
Sector | Technology | Health |
52-Week High | $12.11 | $812.27 |
52-Week Low | $1.99 | $542.52 |
Enterprise Value | $202.19M | $63.47B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
